By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom has sued both Aria Diagnostics and Natera, accusing the companies of infringing a Sequenom patent with their respective noninvasive trisomy 21 and paternity tests.

In its complaint against Aria, filed with the US District Court for the Southern District of California, Sequenom alleges that Aria's prenatal trisomy test infringes its patent, US Patent No. 6,258,540, and that Aria's infringement has been "intentional, deliberate, and willful."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.